Skip to main content
An official website of the United States government

Investigational Drug Steering Committee Task Force Rosters

Immuno-Oncology Task Force

Co-chairs

Jason Luke, M.D., FACP
University of Pittsburgh Hillman Cancer Center
Pittsburgh, PA

Padmanee Sharma, M.D., Ph.D.
University of Texas MD Anderson Cancer Center
Houston, TX

 

Members

Scott J. Antonia, M.D, Ph.D.
Duke University School of Medicine 
Durham, NC

Michael B. Atkins, M.D. 
Georgetown University Medical Center 
Washington D.C.

Nilofer S. Azad, M.D.
Johns Hopkins Sydney Kimmel Comprehensive Cancer Center
Baltimore, MD

Julie R. Brahmer, M.D.
Johns Hopkins Sydney Kimmel Comprehensive Cancer Center 
Baltimore, MD

Margaret Callahan, M.D., Ph.D.
Memorial Sloan Kettering Cancer Center 
New York, NY

Madhav V. Dhodapkar, M.B.B.S.
Emory University Winship Cancer Institute
Atlanta, GA

Lawrence Fong, M.D.
University of California San Francisco 
San Francisco, CA

Brian R. Gastman, M.D.
Cleveland Clinic
Cleveland, OH

Ivana Gojo, M.D. 
Johns Hopkins Sydney Kimmel Comprehensive Cancer Center
Baltimore, MD

F. Stephen Hodi, M.D.
Dana-Farber Cancer Institute 
Boston, MA

Siwen Hu-Lieskovan, M.D., Ph.D.
University of Utah Huntsman Cancer Institute 
Salt Lake City, UT

Jeffrey Miller, M.D., 
University of Minnesota Masonic Cancer Center 
Minneapolis, MN

Aung Naing, M.D., FACP
University of Texas MD Anderson Cancer Center 
Houston, TX

Adekunle Odunsi, M.D., Ph.D.
University of Chicago Comprehensive Cancer Center 
Chicago, IL

Catherine Wu, M.D.
Dana-Farber Cancer Institute 
Boston, MA

Cassian Yee, M.D.
University of Texas MD Anderson Cancer Center  
Houston, TX

 

NCI CCCT Program Director

Steven Reeves, Ph.D.
steven.reeves@nih.gov

 

Pharmacology Task Force

Co-chairs

Jan H. Beumer, Pharm.D., Ph.D., 
University of Pittsburgh Hillman Cancer Center
Pittsburgh, PA

Michelle Rudek-Renaut, Pharm.D., Ph.D.
Johns Hopkins Sydney Kimmel Comprehensive Cancer Center
Baltimore, MD

 

Members

Sharyn D. Baker, Pharm.D, Ph.D.
The Ohio State University College of Pharmacy
Columbus, OH

Stacey Berg, M.D. 
Texas Children's Hospital
Houston, TX

Joga Gobburu, Ph.D., M.B.A.
University of Maryland School of Pharmacy 
Baltimore, MD

R. Donald Harvey, Pharm.D., FCCP, FHOPA
Emory University Winship Cancer Institute 
Atlanta, GA

Jill Kolesar, Pharm.D., M.S., FCCP
University of Kentucky
Lexington, KY

Mitch A. Phelps, Ph.D.
The Ohio State University College of Pharmacy
Columbus, OH

Joel M. Reid, Ph.D., M.S.
Mayo Clinic  
Rochester, MN

Alex Sparreboom, Ph.D., M.Sc.
The Ohio State University College of Pharmacy
Columbus, OH

Jeffrey G. Supko, Ph.D.
Massachusetts General Hospital
Boston, MA

Timothy Synold, Pharm.D.
City of Hope
Duarte, CA

Raman Venkataramanan, Ph.D., M.Pharm.
University of Pittsburgh School of Pharmacy
Pittsburgh, PA

 

 

NCI CCCT Program Director

Steven Reeves, Ph.D.
steven.reeves@nih.gov

 

  • Updated:

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Investigational Drug Steering Committee Task Force Rosters was originally published by the National Cancer Institute.”

Email